ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SHEZF Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK)

0.4696
0.00 (0.00%)
14 Feb 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
CNY (元)CNY (元)CNY (元)CNY (元)CNY (元)CNY (元)CNY (元)CNY (元)
Total Revenue 2.24B2.82B4.79B4.6B5.31B6.34B7.14B5.42B
Operating Income 699.14M879.69M1.9B1.71B2.06B2.01B2.31B1.78B
Pre Tax Income 474.94M104.18M702.18M1.31B1.33B222.26M829.85M-928.33M
Net Income 396.89M196.66M591.46M1.06B1.02B240.79M727.08M-783.26M
Preferred Dividends -311.8M-56.12M-124.72M-224.5M-220.09M-51.36M-146.73M0
Basic Earnings Per Share (EPS) 0.3180.1580.4740.8490.3490.0820.248-0.267
EBIT 279.58M253.9M1.01B904.28M1.55B657.77M951.26M-412.1M
EBITDA 428.01M435.2M1.21B1.06B1.32B969.13M1.4B931.51M

Your Recent History